Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer

NCT03501056 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants enrolled

Conditions

Advanced Lung Cancer

Interventions

BIOLOGICAL: Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Lung cancer
PROCEDURE: Cryotherapy

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators

[object Object]